124 related articles for article (PubMed ID: 10068341)
1. Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival.
Aaltomaa S; Eskelinen M; Lipponen P
Prostate; 1999 Feb; 38(3):175-82. PubMed ID: 10068341
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Ala-Opas M; Kosma VM
Prostate; 1999 Apr; 39(1):8-15. PubMed ID: 10221260
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
4. Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation.
Lipponen P; Aaltomaa S; Kellokoski J; Ala-Opas M; Kosma V
Eur Urol; 2000 May; 37(5):573-8. PubMed ID: 10765096
[TBL] [Abstract][Full Text] [Related]
5. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
Lipponen P; Aaltomaa S; Tammi R; Tammi M; Agren U; Kosma VM
Eur J Cancer; 2001 May; 37(7):849-56. PubMed ID: 11313172
[TBL] [Abstract][Full Text] [Related]
6. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Kosma VM
Br J Cancer; 1999 May; 80(3-4):477-82. PubMed ID: 10408856
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma SH; Lipponen PK; Kosma VM
Anticancer Res; 2001; 21(4B):3101-6. PubMed ID: 11712818
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
Lipponen PK; Eskelinen MJ
Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell cycle-regulated proteins in prostate cancer.
Mashal RD; Lester S; Corless C; Richie JP; Chandra R; Propert KJ; Dutta A
Cancer Res; 1996 Sep; 56(18):4159-63. PubMed ID: 8797586
[TBL] [Abstract][Full Text] [Related]
10. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
[TBL] [Abstract][Full Text] [Related]
11. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
Aaltomaa S; Kärjä V; Lipponen P; Isotalo T; Kankkunen JP; Talja M; Mokka R
Anticancer Res; 2006; 26(6C):4873-8. PubMed ID: 17214354
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group.
Liukkonen T; Lipponen P; Raitanen M; Kaasinen E; Ala-Opas M; Rajala P; Kosma VM
Urol Res; 2000 Oct; 28(5):285-92. PubMed ID: 11127704
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.
Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM
Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance.
Michels JJ; Duigou F; Marnay J; Henry-Amar M; Delozier T; Denoux Y; Chasle J
Cancer; 2003 Mar; 97(6):1376-86. PubMed ID: 12627500
[TBL] [Abstract][Full Text] [Related]
17. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
[TBL] [Abstract][Full Text] [Related]
18. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
19. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM
Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.
Kuczyk MA; Bokemeyer C; Hartmann J; Schubach J; Walter C; Machtens S; Knuchel R; Kollmannsberger C; Jonas U; Serth J
Oncol Rep; 2001; 8(6):1401-7. PubMed ID: 11605074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
